EIR AstraZeneca Pharmaceuticals LP Mar 2021

Viviana Matta FDA, Zhao Wang FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Frederick, MD, United States facility and issued inspectional observation (via FDA 483) on 19 Mar 2021.

Product details

  • Category:
  • Inspection end: 19 Mar 2021
  • Location: Frederick, United States
  • FEI: 3002617771
Add To Cart